
Currently out of the existing stock ratings of Shaunak Deepak, 11 are a BUY (100%).
Analyst Shaunak Deepak, has had 58.33% of price targets met with an average potential upside of 83.92%, reached in 1011 days on average. Previously, Shaunak Deepak worked at HC WAINWRIGHT, JEFFERIES, AVONDALE.
Shaunak Deepak has documented 23 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on FATE, Fate Therapeutics at 20-Mar-2017.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for FATE (FATE THERAPEUTICS) on 7/28/2016. The price target of $9 was fulfilled within 544 days with a profit of $7.02 (354.55%), with a performance score of 6.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Oct-2023
$10
$5.87 (142.13%)
$15
30 days ago
(19-Oct-2026)
0/3 (0%)
$6.91 (223.62%)
Buy Since 24-Nov-2025
$5
$0.87 (21.07%)
$6
1 months 11 days ago
(07-Oct-2026)
4/8 (50%)
$1.55 (44.93%)
94
Buy Since 27-Feb-2026
$13
$8.87 (214.77%)
$14
3 months 12 days ago
(06-Aug-2026)
0/7 (0%)
$9.11 (234.19%)
Buy Since 24-Oct-2019
$10
$5.87 (142.13%)
$8
6 months 11 days ago
(07-May-2026)
5/16 (31.25%)
$6.45 (181.69%)
760
Buy Since 09-Apr-2025
$7
$2.87 (69.49%)
$8
6 months 11 days ago
(07-May-2026)
0/4 (0%)
$3.45 (97.18%)